HOME >> BIOLOGY >> NEWS
Mapping genes for schizophrenia in the South Pacific

ARTICLE: "Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau"

AUTHORS: B. Devlin, Silviu-Alin Bacanu, Kathryn Roeder, Fred Reimherr, Paul Wender, Brandi Galke, Denise Novasad, Allan Chu, Karen T.Cuenco, Seba Tiobek, Caleb Otto, William Byerley

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA; Department of Statistics, Carnegie Mellon University, Pittsburgh, PA; Department of Psychiatry, University of Utah Medical Center, Salt Lake City, Utah; Department of Psychiatry, University of California, Irvine, CA; Department of Genetics, University of Pittsburgh, Pittsburgh, PA; Belau National Hospital, Korror, Palau.

Schizophrenia is a devastating neuropsychiatric disorder that afflicts 1% of the worldwide population. Remarkably, the prevalence of schizophrenia is the same throughout the world despite differing cultures and environments of most nations. It is also notable that the cardinal signs and symptoms of schizophrenia - hallucinations and delusions - are the same throughout the world. In addition, family, twin and adoption studies from different populations indicate genetic factors contribute substantially to susceptibility to this illness. Small, isolated populations can be useful for gene mapping for two reasons: the genetic causes of illness are typically less heterogeneous, and isolated populations often contain large extended multiplex pedigrees ideal for mapping genes. For these reasons, the investigators initiated a genetic study of schizophrenia in Palau, Micronesia. Palau, also termed Belau, which is located approximately 725 miles southwest of Guam in the South Pacific. Presentation and symptoms of schizophrenia are no different in Palau.

The study findings, published in the September issue of Molecular Psychiatry, indicate that the genetic factors are distinct for each of the 5 families. The findings were perhaps somewhat unexpecte
'"/>

Contact: Frank Sissingh
molecularpsychiatry@mednet.ucla.edu
310-206-6739
Molecular Psychiatry
3-Sep-2002


Page: 1 2

Related biology news :

1. Mapping the evolution of a virus
2. Organization for Human Brain Mapping 2004 Annual Meeting
3. Mapping a road to understanding human health
4. Organization for Human Brain Mapping annual meeting abstract highlights
5. Organization for Human Brain Mapping 2003 Annual Meeting
6. Mapping proteins
7. Elementary Students Mapping Virginia Wildlife
8. Rare Brain Mapping Procedure Provides Unique Picture Of Two Areas Concerned With Language Processing and Production
9. Subterranean Mapping Method Will Find Homes For Pollution-Eating Bacteria
10. Mapping The Way To A Bigger Prawn
11. Brain Mapping In Real Time

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mapping genes for schizophrenia the South Pacific

(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: